S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(1.45%) $922.85
USD/EUR
(0.11%) $0.928
USD/NOK
(0.28%) $10.87
USD/GBP
(-0.03%) $0.792
USD/RUB
(-0.03%) $92.55

Realtime updates for JW THERAP-B [2126.HK]

Exchange: HKSE Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 04:08

0.55% HKD 1.830

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 04:08):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors...

Stats
Today's Volume 230 000
Average Volume 401 628
Market Cap 735.93M
EPS HKD0 ( 2024-03-20 )
Next earnings date ( HKD0 ) 2024-04-24
Last Dividend HKD0 ( N/A )
Next Dividend HKD0 ( N/A )
P/E -0.900
ATR14 HKD0.0140 (0.79%)

JW THERAP-B Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

JW THERAP-B Financials

Annual 2022
Revenue: HKD145.70M
Gross Profit: HKD58.76M (40.33 %)
EPS: HKD-2.06
Q2 2023
Revenue: HKD87.74M
Gross Profit: HKD44.81M (51.07 %)
EPS: HKD-0.930
Q4 2022
Revenue: HKD79.70M
Gross Profit: HKD35.63M (44.70 %)
EPS: HKD-1.010
Q2 2022
Revenue: HKD66.01M
Gross Profit: HKD23.13M (35.04 %)
EPS: HKD-1.050

Financial Reports:

No articles found.

JW THERAP-B

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, the People's Republic of China.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators